newsfilter
← Latest News
Business Wire·

Exicure, Inc. Reports First Quarter 2024 Financial Results

Exicure, Inc. (NASDAQ:XCUR, the "Company")), has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. In September